Russell Frank Company’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2016
Q1 | $26.1M | Sell |
187,099
-109,019
| -37% | -$15.2M | 0.05% | 476 |
|
2015
Q4 | $56.7M | Buy |
296,118
+3,149
| +1% | +$602K | 0.1% | 235 |
|
2015
Q3 | $45.8M | Sell |
292,969
-8,526
| -3% | -$1.33M | 0.09% | 253 |
|
2015
Q2 | $54.5M | Buy |
301,495
+59,361
| +25% | +$10.7M | 0.09% | 257 |
|
2015
Q1 | $42M | Buy |
242,134
+67,472
| +39% | +$11.7M | 0.08% | 300 |
|
2014
Q4 | $32.3M | Buy |
174,662
+13,896
| +9% | +$2.57M | 0.06% | 380 |
|
2014
Q3 | $26.7M | Sell |
160,766
-30,370
| -16% | -$5.04M | 0.05% | 439 |
|
2014
Q2 | $31.7M | Buy |
191,136
+74,054
| +63% | +$12.3M | 0.06% | 379 |
|
2014
Q1 | $17.8M | Buy |
117,082
+68,597
| +141% | +$10.4M | 0.03% | 599 |
|
2013
Q4 | $7.7M | Sell |
48,485
-44,012
| -48% | -$6.99M | 0.01% | 986 |
|
2013
Q3 | $10.7M | Sell |
92,497
-21,421
| -19% | -$2.49M | 0.02% | 862 |
|
2013
Q2 | $10.5M | Buy |
+113,918
| New | +$10.5M | 0.02% | 827 |
|